Encapsulated antacid dispersions

Details Encapsulated antacid dispersions Encapsulated antacid dispersions

1983-03-15

1984-12-04

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Monoclonal antibody or fragment thereof

424157, 424128, 424127, 424154, 424319, 424 31, A61K 3310, A61K 3308, A61K 3306, A61K 3342

Patent

active

044864124

ABSTRACT:
Pharmaceutical unit dosage forms comprising dispersions of basic salts in a carrier mixture comprising polyalkylene glycols and a C.sub.2 -C.sub.5 polyol encapsulated in soft gelatin capsules are prepared without deleteriously affecting the stability of the capsules.

REFERENCES:
patent: 3767794 (1973-10-01), McVean et al.
patent: 3843778 (1974-10-01), Diamond et al.
patent: 4002718 (1977-01-01), Gardella et al.
patent: 4067960 (1978-01-01), Fadda
patent: 4088750 (1978-05-01), Cresswell et al.
patent: 4150110 (1979-04-01), Yoshida et al.
patent: 4198391 (1980-04-01), Grainger
Handbook of Nonprescription Drugs, Fifth Ed., 1977, American Pharmaceutical Association, Wash., D.C., pp. 13 & 17.

Affiliated with

Also associated with

Rating

Encapsulated antacid dispersions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Encapsulated antacid dispersions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Encapsulated antacid dispersions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1581911